Code | Product Name | Composition | Dosage Form | Administration Route | Container |
---|---|---|---|---|---|
15-AC0-008 | Doxorubicin hydrochloride | Doxorubicin hydrochloride 50 mg | Powder for solution for injection | Vial | |
15-AC0-008 | Doxorubicin hydrochloride | Doxorubicin hydrochloride 50 mg | Solution for injection | Vial | |
15-AC0-018 | Doxorubicin (as Doxorubicin hydrochloride liposomal pegylated) concentrate | Doxorubicin (as Doxorubicin hydrochloride liposomal pegylated) 2mg/ml concentrate | Solution for injection/infusion | Intravenous | Vial |
15-AC0-012 | Mitomycin | Mitomycin 2mg | Powder for solution for injection | Intravenous | Vial |
15-AC0-013 | Mitomycin | Mitomycin 10mg | Powder for solution for injection | Intravenous | Vial |
15-AC0-014 | Mitoxantrone (Mitozantrone) as hydrochloride | Mitoxantrone (Mitozantrone) as hydrochloride 2mg/ml | Concentrate for solution for injection/infusion | Intravenous | Vial |
15-AD0-004 | Etoposide | Etoposide 20mg/ml | Concentrate for solution for injection/infusion | Intravenous | Vial |
15-AD0-007 | Vincristine sulphate | Vincristine sulphate 1mg/ml | Solution for injection | Intravenous | |
15-AD0-011 | Vinorelbine (as tartrate) | Vinorelbine (as tartrate) 10 mg/ml | Concentrate for solution for injection/infusion | Intravenous | Vial |
15-AF0-049 | Oxaliplatin | Oxaliplatin 5mg/ml | Solution for injection/infusion | Intravenous | Vial |